RASA2 ablation in CAR T-cells resulted in a slight upward trend in binding strength against SJ-DIPGX7c but did not reach statistical significance ( figure 4E,F ).
← all excerpts
RASA2 deletion rescues immune synapse dysfunction, enhancing CAR T cell efficacy against DMGs.
1
—
—